Abstract:Background: While reporting of adverse drug events (AE) and adverse drug reactions (ADR) following Chinese materia medica (CM) injection is becoming more common, the reporting quality is of concern. Methods: A checklist about the reporting quality of AE/ADR was set up, and the ADR/AE reporting of Herba Houttuyniae injection was chosen as an example. Electronic databases Chinese Journal Net (1994-2009) and Chinese Science and Technological Journal Net (VIP) (1989-2009) were searched for target literature. Results: Based on our search strategy, 210 articles were included, with 175 articles reporting single or several cases of ADR/AE following Herba Houttuyniae injection (type I report). There were seven reports from regional or national ADR monitoring centers (type II report), and 28 summary reports from a single hospital or medical center (type III report). All 210 papers mentioned "adverse effect,""safety" or related meaning words in their titles, but 199 articles did not have abstract. Patient demographic characteristics were not fully reported in these articles. In type I articles, only 97 cases (43.11%) mentioned whether patients had or did not have a history of allergies, whereas 128 cases (56.89%) in type II papers and 14 (50%) type III papers, did not mention allergic history of patients. Only three articles (3/210, 1.43%), all of them type I, mentioned the syndrome type in Chinese medicine. None of the papers gave clear indications of the type and grade of ADR/AE of patients. Most papers did not report details of the CM injection procedure, such as the drug company, product serial number, or the drug's validity period. Data about the occurrence time and management of ADR/AE was also inadequately reported. Conclusion and recommendations: The current reporting format of ADR/AE in clinical CM injections is not standardized. Much fundamental information of ADR/AE following CM injection is therefore missing. A standard reporting format for ADR should be developed, and should include the following: (1) a title mentioning adverse effects and safety; (2) a structured abstract including adequate information about the patient and the disease treated, the drug used, the specific ADR/AE, physician response to the ADR/AE, and result of management; (3) demographic characteristic of the patients (gender, age, etc.); (4) clinical characteristics of patients (disease, syndrome, etc); (5) allergic history of patients; (6) diagnosis and syndrome based on Chinese medicine theory; (7) detailed information about the CM intervention (the manufacturer of the drug, series number, valid dates, dosage, route of administration, menstruum, dripping speed, etc.); (8) concomitant drug use; (9) time and symptoms of ADR/AE; (10) type and grading of ADR/AE; (11) physiological systems affected by ADR/AE; (12) specific treatment and prognosis for ADR/AE; (13) evidence of the cause and effect of ADR/AE; and (14) any other possibility of ADR/AE. Also, a ADR/AE registration system should be established.

The Analysis and Evaluation of Adverse Reactions Caused by TCM Decoction

[Analysis on the Common Causes for Traditional Chinese Medicinal Injection Induced Adverse Reactions and the Preventive Countermeasures].

Case Series Reports of 52 Allergic Rhinitis Adults Treating by Tuomin Zhiti Decoction

[Retrospective Analysis and Discussion on 74 Cases of Adverse Reactions of Traditional Chinese Medicine Injection].

Analysis of Adverse Reaction of Common Chinese Herbs with Antirheumatic Activity

The Diagnosis and Management of Allergic Reactions Caused by Chinese Materia Medica

Analysis of 136 ADRs Induced by Chinese Patent Medicine

Safety profile of traditional Chinese herbal injection: An analysis of a spontaneous reporting system in China

Exploration on Judgment Method of Allergens in the TCM Decoction

Safety Research in Traditional Chinese Medicine: Methods, Applications, and Outlook

Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases

Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica

Discussion on Drug Reevaluation by Analyzing Adverse Drug Reaction of Traditional Chinese Medicine Injection

Adverse Drug Reactions Induced by Traditional Chinese Medicines in Our Hospital: Analysis of 145 Cases

Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China

Analysis of Adverse Drug Reaction of NSAIDs Reported in Domestic Medical Journals Within Past 43 Years

Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis

'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors

Research progress and frontier of integrated analysis of "toxicity" and "effect" of Traditional Chinese Medicine

Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review

Pseudo-allergic reactions induced by Chinese medicine injections: a review